Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 222

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 222
---
 that are not exercisable until December 23, 2025. |

| (3) | Excludes, for beneficial ownership purposes, 9,436 warrants to purchase common stock purchased in the (1) Offering that are not exercisable until December 23, 2025. |

| (4) | Excludes, for beneficial ownership purposes, 20,000 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (5) | Excludes, for beneficial ownership purposes, 75,472 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (6) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (7) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (8) | Excludes, for beneficial ownership purposes, 113,208 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (9) | Excludes, for beneficial ownership purposes, 150,944 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (10) | Excludes, for beneficial ownership purposes, 75,472 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (11) | The securities reported are held directly by the James D. Kollefrath 2017 Irrevocable Trust, and may be deemed to be beneficially owned by Caroline Nyberg, as trustee. Caroline Nyberg disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |

| (12) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (13) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (14) | The reported securities are held directly by Norton Capital LLC